The regulations on arrangements for dealing with major incidents,' issued in October 1990, required all listed hospitals to draw up a major incident plan, designate a medical incident officer, and arrange for a mobile medical team. This study investigates the extent to which hospitals have responded to the last two provisions.
Methods and results
I sent a questionnaire to 100 randomly selected accident and emergency departments. Non-responders were contacted once by telephone. The questionnaire asked the identity and training of the medical incident officer; the members, training, and experience of the mobile medical team; and whether action cards were issued.
Ninety three departments returned questionnaires. Five departments were excluded from analysis because the procedures were undergoing major revision, leaving 88 for analysis.
The medical incident officer was a member of an immediate care team in six hospitals, a hospital consultant in 80 hospitals, and a senior house officer in two. Twenty nine departments specified an accident and emergency consultant and eight a member of the hospital flying squad. Eight had chosen physicians, eight anaesthetists, five orthopaedic surgeons, 10 obstetricians or urologists, and 14 other specialists. Training was given through practical exercises in 16 departments, 
Comment
The effects of cisapride on heart rate are not to be expected from the known pharmacology of the drug and seem not to have been previously described in clinical practice. The mechanism by which tachycardia may be induced is not obvious. One explanation could be the structural similarity between cisapride and metoclopramide. Both are structurally related to the antiarrhythmic agent procainamide. Tachycardia has been described with metoclopramide34 and is known to occur occasionally with procainamide.
In our opinion these seven cases strongly indicate that cisapride may occasionally induce tachycardia. In three of the patients symptoms recurred upon reexposure to cisapride. An additional two patients received no treatment other than cisapride. Other confounding factors have not been identified, though one patient (case 4) had had a recent operation for coarctation of the aorta; rechallenge with cisapride after two days, however, resulted in more extrasystoles. We postulate that cisapride may induce tachycardia through a procainamide-like effect of prolonging the conduction time through the atrioventricular node. Further pharmacological studies are warranted to elucidate the exact effects of cisapride on the heart. These reports are from several countries belonging to the WHO Collaborating Programme, and the information has been gained and primarily assessed in different ways. Causality thus cannot be simply determined from the information available, and our analysis of the data does not represent the opinion of the World Health Organisation. 
